C
Charles M. Cleland
Researcher at New York University
Publications - 232
Citations - 6688
Charles M. Cleland is an academic researcher from New York University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 42, co-authored 208 publications receiving 5696 citations. Previous affiliations of Charles M. Cleland include National Development and Research Institutes & University of Maryland, College Park.
Papers
More filters
Journal ArticleDOI
Prevalence and Characteristics of Chronic Pain Among Chemically Dependent Patients in Methadone Maintenance and Residential Treatment Facilities
Andrew Rosenblum,Herman Joseph,Chunki Fong,Steven Kipnis,Charles M. Cleland,Russell K. Portenoy +5 more
TL;DR: Chronic severe pain is prevalent among patients in substance abuse treatment, especially MMTP patients, and self-medication for pain with psychoactive drugs appears especially problematic among substance users who enroll in drug-free treatment programs.
Journal ArticleDOI
The Effects of Behavioral/Cognitive-Behavioral Programs on Recidivism
TL;DR: The CDATE project coded studies of treatment/intervention programs in prison, jail, probation, or parole settings reported from 1968 through 1996 as mentioned in this paper, and meta-analyses were conducted on the 69 primary research studies on the effectiveness of behavioral and cognitive-behavioral treatment in reducing recidivism for offenders.
Journal ArticleDOI
Prescription opioid abuse among enrollees into methadone maintenance treatment.
Andrew Rosenblum,Mark Parrino,Sidney H. Schnoll,Chunki Fong,Carleen Maxwell,Charles M. Cleland,Stephen Magura,J. David Haddox +7 more
TL;DR: A multi-state survey of opioid dependent persons enrolling in 72 methadone maintenance treatment programs was conducted to determine the prevalence of prescription opioid (PO) abuse, factors associated with PO abuse and sources for POs.
Journal ArticleDOI
Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men.
TL;DR: The high reinfection rates and the attributable risk analysis suggest the existence of a subset of HIV-positive MSM with recurring sexual exposure to HCV, which is likely to become chronic and liver fibrosis progression is accelerated in this population.
Journal ArticleDOI
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007.
Barbara Tempalski,Enrique R. Pouget,Charles M. Cleland,Charles M. Cleland,Joanne E. Brady,Hannah L.F. Cooper,H. Irene Hall,Amy Lansky,Brooke S. West,Samuel R. Friedman,Samuel R. Friedman +10 more
TL;DR: Overall PWID rates remained constant since 2002, but increased for two subpopulations: non-Hispanic black PWID and young PWID, and this rate declined during the early period and then was relatively stable in 2002–2007.